Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:42 PM
Ignite Modification Date:
2025-12-24 @ 6:42 PM
NCT ID:
NCT01936857
Eligibility Criteria:
Inclusion Criteria:
* HIV positive
* Current moderate or severe Diagnostic and Statistical Manual (DSM-V) opioid use disorder
* Urine drug screen positive for opioids
* Interested in receiving treatment for opioid dependence
* Age at least 18 years old
* Willing to practice an effective method of birth control, if female
Exclusion Criteria:
* Known hypersensitivity to buprenorphine or naloxone
* aspartate aminotransferase (AST) \& alanine aminotransferase (ALT) \> 5x upper limit
* Currently pregnant or breastfeeding
* Serious medical or psychiatric illness in past 30 days (e.g. opportunistic infection, psychosis) that precludes safe participation in the opinion of study physician
* Methadone maintenance treatment within 30 days of consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01936857
Study Brief:
Protocol Section:
NCT01936857